These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22379926)
1. Evaluation of HPV DNA HR assay in females as a marker of recurrent disease following treatment of cervical intraepithelial neoplasia. Mikolajczyk K; Kedzia W; Zaba R; Silny W Ginekol Pol; 2011 Sep; 82(9):670-4. PubMed ID: 22379926 [TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225 [TBL] [Abstract][Full Text] [Related]
3. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596 [TBL] [Abstract][Full Text] [Related]
4. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia. Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129 [TBL] [Abstract][Full Text] [Related]
5. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia]. Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326 [TBL] [Abstract][Full Text] [Related]
6. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Zielinski GD; Rozendaal L; Voorhorst FJ; Berkhof J; Snijders PJ; Risse EJ; Runsink AP; de Schipper FA; Meijer CJ Gynecol Oncol; 2003 Oct; 91(1):67-73. PubMed ID: 14529664 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study. Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574 [TBL] [Abstract][Full Text] [Related]
8. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826 [TBL] [Abstract][Full Text] [Related]
9. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP. Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women. Kang WD; Kim SM Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824 [TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. Jeong NH; Lee NW; Kim HJ; Kim T; Lee KW J Obstet Gynaecol Res; 2009 Aug; 35(4):706-11. PubMed ID: 19751331 [TBL] [Abstract][Full Text] [Related]
12. [Clinical value of p16 Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350 [No Abstract] [Full Text] [Related]
13. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia. Kudoh A; Sato S; Itamochi H; Komatsu H; Nonaka M; Sato S; Chikumi J; Shimada M; Oishi T; Kigawa J; Harada T Int J Clin Oncol; 2016 Jun; 21(3):580-7. PubMed ID: 26614089 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study on cervical intraepithelial neoplasia with high-risk HPV infection among pregnant women]. He Y; Wu YM; Wang T; Song F; Wang Y; Zhao Q; Kong WM; Duan W; Zhu L; Zhang WY Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):598-602. PubMed ID: 23141180 [TBL] [Abstract][Full Text] [Related]
16. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus]. Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008 [TBL] [Abstract][Full Text] [Related]
17. The significance of HPV in the follow-up period after treatment for CIN. Gallwas J; Ditsch N; Hillemanns P; Friese K; Thaler C; Dannecker C Eur J Gynaecol Oncol; 2010; 31(1):27-30. PubMed ID: 20349777 [TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610 [TBL] [Abstract][Full Text] [Related]
19. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Nagai Y; Maehama T; Asato T; Kanazawa K Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660 [TBL] [Abstract][Full Text] [Related]
20. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier. Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]